rVA576 in Adult Mild to Moderate Bullous Pemphigoid Subjects

NCT04035733 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Bullous Pemphigoid (BP)

Interventions

DRUG: rVA576

Sponsor

AKARI Therapeutics